NDC 70801-002 - Zilretta
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70801-002
- Package NDCs from labels
- 70801-002-01, 70801-002-02
- Manufacturer
- Flexion Therapeutics, Inc. | Packaging Coordinators, LLC (PCI) | Catalent Indiana, LLC | Synergy Health Sterilisation UK Ltd | Patheon UK Limited | Farmabios S.p.A. | Alcami Carolinas Corporation
- Effective date
- 2022-12-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| triamcinolone acetonide extended-release injectable suspension | Flexion Therapeutics, Inc. | Packaging Coordinators, LLC (PCI) | Catalent Indiana, LLC | Synergy Health Sterilisation UK Ltd | Patheon UK Limited | Farmabios S.p.A. | Alcami Carolinas Corporation | 2022-12-29 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Preferred Pharmaceuticals Inc | adc16c6b-b508-48b8-af8c-a5f03f2955fe | 2025-10-01 | Adverse reactions | F446C597KA |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Preferred Pharmaceuticals, Inc. | a1633e66-2ce8-42e4-8046-ac10dadfa34b | 2025-10-01 | Adverse reactions | F446C597KA |
| Triamcinolone acetonide | TRIAMCINOLONE ACETONIDE | Preferred Pharmaceuticals Inc. | 777c3cb9-da2b-431c-934f-f3c70f93d6cb | 2025-10-01 | Adverse reactions | F446C597KA |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Preferred Pharmaceuticals Inc. | 99f8a0e6-8ee8-4430-b1d5-1022da1d72ab | 2025-10-01 | Adverse reactions | F446C597KA |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | Encube Ethicals, Inc. | a20baaac-002d-40ac-9c7b-f92e8ee987ea | 2025-09-25 | Adverse reactions | F446C597KA |
| Jet Lag | ECHINACEA, ALUMINA, ARALIA QUINQUEFOLIA, ARGENTUM, ARNICA MONTANA, ARSENICUM ALBUM, BAPTISIA TINCTORIA, BRYONIA, CANTHARIS, CHELIDONIUM MAJUS, CONIUM MACULATUM, GELSEMIUM SEMPERVIRENS, IODIUM, KALI CARBONICUM, KALI IODATUM, LYCOPODIUM CLAVATUM, LYCOPUS VIRGINICUS, NATRUM MURIATICUM, NUX VOMICA, PHOSPHORUS, PHYTOLACCA DECANDRA, PULSATILLA, RHUS TOXICODENDRON, SABAL SERRULATA, THYROIDINUM. | Newton Laboratories, Inc. | 9c21c935-4ebc-1efd-e053-2995a90aa156 | 2025-09-18 | Warnings | 451W47IQ8X |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Sun Pharmaceutical Industries, Inc. | b353c8b1-9088-4969-8199-37876f2461cc | 2025-09-15 | Adverse reactions | F446C597KA |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | ProPharma Distribution | 3edd3ad8-2561-59b5-e063-6294a90a0165 | 2025-09-15 | Warnings, Adverse reactions | F446C597KA |
| REFRESH OPTIVE Drops | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 80275190-d717-40ea-905b-5c8fbe986eac | 2025-09-15 | Warnings | K679OBS311 |
| Refresh Relieva PF Xtra | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | b51b8a75-8faa-430f-8f7e-ee58d3d13f2e | 2025-09-15 | Warnings | K679OBS311 |
| Refresh Relieva | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Allergan, Inc. | 6b984fa2-4187-45ef-b7d3-15e720abc667 | 2025-09-15 | Warnings | K679OBS311 |
| Lubricant Drops | CARBOXYMETHYLCELLULOSE SODIUM | CARDINAL HEALTH 110, LLC. DBA LEADER | 1ac2fe24-9ff6-48c1-b123-fbc0e48f5304 | 2025-09-12 | Warnings | K679OBS311 |
| Dry Eye Relief | CARBOXYMETHYLCELLULOSE SODIUM | CARDINAL HEALTH 110, LLC. DBA LEADER | bd262028-32e9-052d-e053-2a95a90a5303 | 2025-09-12 | Warnings | K679OBS311 |
| GAVILYTE-N | POLYETHYLENE GLYCOL-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE AND SODIUM BICARBONATE | Lupin Pharmaceuticals,Inc. | 27195187-75a3-431f-90d9-84da1b94e849 | 2025-09-10 | Warnings, Adverse reactions | 451W47IQ8X |
| GaviLyte - C TM | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES WITH FLAVOR PACK | Lupin Pharmaceuticals,Inc. | a8b15625-ca7c-4d57-9f36-3ac2a6d13665 | 2025-09-10 | Warnings, Adverse reactions | 451W47IQ8X |
| GAVILYTE G TM | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | Lupin Pharmaceuticals,Inc. | 3978822b-6473-4072-9f80-20ceb9bea355 | 2025-09-10 | Warnings, Adverse reactions | 451W47IQ8X |
| Schuessler Tissue Salts Comb 12 General Tonic | CALCAREA FLUORICA,CALCAREA PHOSPHORICA,CALCAREA SULPHURICA,FERRUM PHOSPHORICUM,KALI PHOSPHORICUM,KALI MURIATICUM,KALI SULPHURICUM,MAGNESIA PHOSPHORICA,NATRUM MURIATICUM,NATRUM PHOSPHORICUM,NATRUM SULPHURICUM,SILICEA | Martin & Pleasance Pty Ltd | 9083a01b-2fbe-4e04-9eec-bf4f65950ec7 | 2025-09-09 | Warnings | 451W47IQ8X |
| Schuessler Tissue Salts Comb 12 General Tonic | CALCAREA FLUORICA,CALCAREA PHOSPHORICA,CALCAREA SULPHURICA,FERRUM PHOSPHORICUM ,KALI PHOSPHORICUM,KALI MURIATICUM,KALI SULPHURICUM,MAGNESIA PHOSPHORICA,NATRUM MURIATICUM,NATRUM PHOSPHORICUM,NATRUM SULPHURICUM,SILICEA | Martin & Pleasance Pty Ltd | c14c79ab-85bb-45f2-83d1-1d9c298ffdfd | 2025-09-08 | Warnings | 451W47IQ8X |
| Polyethylene Glycol 3350 and electrolytes - Unflavored | POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES - UNFLAVORED | Strides Pharma Science Limited | 48c741a9-9039-4fdb-a875-86d4ea968282 | 2025-09-05 | Warnings, Adverse reactions | 451W47IQ8X |
| Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride - Unflavored | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE - UNFLAVORED | Strides Pharma Science Limited | 37c111ec-5b62-42b9-bbb2-3b0c530e34c9 | 2025-09-01 | Warnings, Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.